SIG Brokerage’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
SIG Brokerage's VRTX Position: Q2 2026 in Review
SIG Brokerage increased its Vertex Pharmaceuticals (VRTX) stake by 27% in Q2 2026, buying an estimated $2.12M and bringing the position to 22,390 shares worth $11.1M. The position accounts for 0.22% of the portfolio, ranked #85.
SIG Brokerage first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.5M in Q2 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- SIG Brokerage held 22,390 shares of Vertex Pharmaceuticals worth $11.1M as of Q2 2026.
- SIG Brokerage bought 4,785 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.12M.
- Vertex Pharmaceuticals made up 0.22% of SIG Brokerage's portfolio in Q2 2026, its #85 holding.
- SIG Brokerage first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- SIG Brokerage's Vertex Pharmaceuticals position peaked at $14.5M in Q2 2025.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.